Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The aurora kinase B pseudogene (ENSG00000271357) is a nonfunctional genomic sequence related to the aurora kinase B gene. Like other pseudogenes, it does not encode a functional protein product due to mutations or gene disruptions that have accumulated over evolutionary time. Pseudogenes can sometimes be transcribed into noncoding RNAs that may influence the regulation of their parent genes, but they are not conventional molecular targets for drug development or disease treatment[2][1]. In summary, ENSG00000271357 is not a druggable target and should not be considered a functional gene or protein for therapeutic purposes. If the intention was to find information on the active enzyme "Aurora kinase B," the correct entity would be "Aurora kinase B" (AURKB), which is a serine/threonine kinase involved in mitosis and a cancer therapy target, but ENSG00000271357 pertains to a nonfunctional pseudogene instead[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aurora kinase B pseudogene.